Annihilating efficacy of Euphorbia hirta L. extracts on Artemia salina Nauplii and human breast adenocarcinoma cells (MCF-7 & MDA-MB-231) by Elankanni, Ramasamy et al.
Journal of Phytology 2021, 13: 91-94
doi: 10.25081/jp.2021.v13.6969
https://updatepublishing.com/journal/index.php/jp
J Phytol • 2021 • Vol 13  91 
INTRODUCTION
Cancer is well-known as a multifactorial disease due to abnormal 
proliferation of cells and is one of the major causes of death 
worldwide. Various genetic and epigenetic events create an 
accumulative phenomenon that lead to cancer development 
and progression (Wang et al., 2001). Treatment of cancer is 
particularly challenging and it inflicts a severe burden on the 
public health system. Conventional chemotherapy is associated 
with anticancer drugs with low therapeutic index and results 
in severe side effects (Khandare et al., 2006). Recent evidences 
suggest that natural products are good sources for the treatments 
of human diseases. Medicinal plants have been used to treat 
human diseases for centuries (Sharma and Moin, 2020). 
According to the World Health Organisation (WHO) few 
nations still rely on plant-based treatment as their main source 
of medicine (Parasuraman et al., 2014). The history dates back 
to several years in using plants for their medicinal benefits, 
especially for cancer (Conforti et al., 2008). Chemotherapy 
seems to be promising where 65% of the drugs used are of 
natural origin (Cragg & Newman, 2005). Due to the above-said 
reasons, medicinal plants might prove potential to aid in the 
development of alternative therapy against cancer.
Euphorbia hirta L. is a very popular herb amongst practitioners 
of traditional herbal medicine and belongs to the Euphorbiaceae 
family. Traditionally, aqueous extracts of various E. hirta L. 
parts were noted to be used to treat various syndromes that 
include hay asthma, bowel disease, cough, bronchial disease, 
worm infestation, kidney stones, to decrease lactation, etc. 
They were also recorded for their benefits as a sedative, 
anxiolytic, analgesic, antipyretic, and anti-inflammatory 
agent. Furthermore, studies revealed that E. hirta L. possesses 
galactogenic, anti-anaphylactic, antimicrobial, antioxidant, 
anticancer, anti-feedant, antiplatelet aggregation, anti-
inflammatory, aflatoxin inhibition, antifertility, anthelmintic, 
anti-plasmodial, anti-amoebic, antimalarial and larvicidal 
activities (Rajeh et al., 2010). Based on the afore-mentioned 
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literature, the aqueous and methanol extracts of E. hirta L. 
were investigated to identify potential anticancer properties.
MATERIALS AND METHODS
Plant Materials
The fresh plants of E. hirta L. was collected from its natural 
habitat from Indur village of Dharmapuri district (Tamil Nadu, 
India). Collected specimens were recorded by maintaining a 
voucher specimen (GACDPIEH1) in the laboratory for future 
references. Whole plants were subjected to shade drying and 
powdered coarsely in a mechanical mixer-grinder.
Preparation of Extracts
Hot extraction was performed in a soxhlet apparatus for the 
powdered plant material using methanol and water as solvents 
[sample (g): methanolic/aqueous) = 1:6 ratio]. Obtained 
extracts were then concentrated in rotavapor R-215 (BUCHI 
Labortechnik AG, Switzerland) under reduced pressure 
(72 mbar) at 40 °C to yield dry extracts. Concentrated extracts 
were then stored in a vacuum desiccator at room temperature 
until further use. The extracts were named as EHA (Euphorbia 
hirta L. aqueous) and EHM (Euphorbia hirta L. methanol).
Brine Shrimp Lethality Assay (BSLA)
Toxicity of the plant extracts were evaluated primarily on 
brine shrimp, Artemia salina nauplii. The lethality assay was 
performed following the method of Meyer et al. (1982). Briefly, 
eggs were obtained from STORI Salt Lake Artemia Cysts, 
Fish Cave Seller, Howrah, WB, India and stored at 4°C in a 
refrigerator until further use. 1g of the cysts was sprinkled into 
the glass container (1L capacity) containing sterile artificial 
sea water (prepared by dissolving 38g of sea salt in 1 litre of 
sterile water) for hatching. This setup was incubated at room 
temperature (25-29°C) for 24hrs with strong aeration and 
continuous light regime. Following which, newly hatched pink-
coloured free-swimming nauplii were harvested from the bottom 
of the container. Different dilutions of the plant extracts for this 
assay were prepared by adopting the procedure of McLaughlin 
et al. (1998). 20mg of the aqueous and methanol plant extracts 
were separately dissolved in 2ml of suitable solvents (stock 
solution). These were further diluted to prepare a series of 
concentrations 1000, 100, 10, and 1ppm (μg/ml).
The assay system was prepared with 4.5ml of sterile seawater 
containing 0.5ml of the chosen concentration of the plant 
extracts in watch glass and transferred with 10 nauplii. The setup 
was allowed to remain for 24hrs, under constant illumination of 
florescent lamp and the number of survived and dead nauplii 
were counted and recorded with a hand lens. Larvae were 
considered dead if they did not exhibit any internal or external 
movement during several seconds of observation. Experiments 
were performed in triplicates including solvent and a negative 
control. Percentage mortality of the extracts was calculated 
using the formula: % Mortality= No. of dead nauplii/Total 
No. of nauplii×100. LC50 values were estimated using a probit 
regression analysis (Finney, 1971) at 95% confidence intervals.
Cell Cultures and Maintenance
MDA-MB-231 (human breast carcinoma), MCF-7 (human 
breast carcinoma) and VERO (African Monkey kidney 
epithelial) cell lines were procured from National Centre for Cell 
Science (Pune, India). MDA-MB-231 cells were maintained in 
L-15 (Leibovitz’s) culture medium, and MCF-7 and VERO were 
maintained in Minimum essential medium (MEM) (Eagle) with 
Non-essential amino acids, all with 10% fetal bovine serum in a 
humidified atmosphere at 37ºC (with 5% CO2 for MCF-7 and 
VERO only). The cell lines were maintained in their growing 
phase at 70% confluency with regular passaging.
Cytotoxicity Assay
MTT assay was performed as described by Mosmann (1983) 
with slight modifications. Briefly, a 96-well plate was seeded 
with a cell concentration of 10,000 cells from column 2-11 
and each well were made up to 200μl using respective fresh 
medium. 200µl of fresh culture medium alone was loaded in 
control columns 1 and 12. All sides of the plate was sealed and 
incubated at 37ºC in a humidified atmosphere for 24hrs. After 
24hrs, existing medium was aspirated and wells were replenished 
with 200μl of media containing varying concentrations (12.5, 
25, 50, 100, 200μg/ml) of plant extracts and incubated for 
24hrs. After incubation, the extract medium was aspirated 
and fresh medium was added along with 10μl MTT reagent 
(final concentration of 0.45μg/ml). The plate was then covered 
with aluminium foil and placed for incubation in a humidified 
atmosphere for 4 hours at 37ºC. After which, the medium with 
MTT was removed and 100μl Solubilization solution (DMSO) 
was added to each well to dissolve formazan crystals. Absorbance 
was recorded at 570 nm using a Dynex Opsys MRTM Microplate 
Reader (Dynex Technologies, VA, USA) with a 630nm reference 
filter. Wells containing cells without extract treatments served 
as the control. Percentage cytotoxicity was calculated by using 
the formula:
% Cytotoxicity = 
 Ac - A  x 100
                     Ac
Where, Ac is the Absorbance of control cells and A is the 
absorbance of the extract treated cells
The IC50 value was determined by using linear regression 
equation i.e. Y = Mx+C.
Here, Y = 50, M and C values were derived from the viability 
graph.
Statistical Analysis
All analyses were carried out in triplicates. For each assay, 
data were presented as mean±SD from three independent 
experiments (n = 3). Statistical analyses were performed by 
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one-way ANOVA and significant differences between groups 
were determined at P<0.05. To evaluate relationships between 
experimental parameters, results were analyzed for correlation 
and tested for significance by Student’s t-test (P<0.05). 
MATLAB ver. 7.0 (Natick, MA, USA), GraphPad Prism 5.0 (San 
Diego, CA, USA) and Microsoft Excel 2007 (Roselle, IL, USA) 
were used for the statistical and graphical evaluations.
RESULTS AND DISCUSSION
Cancer is the most common and deadly diseases in the modern 
era and in addition, adverse effects of synthetic anticancer drugs 
are the major limitations in treating cancer. In Asian cultures, 
medicinal plants are used traditionally to prevent and treat 
cancers. Medicinal plants have been reported as a good source 
for the discovery of new chemotherapeutic drugs with high 
efficiency and fewer side effects (Harvey & Cree, 2010).
Yield of extracts
Extraction is an important step for the detection of bioactive 
components from plant materials. With the aid of a solvent, 
desirable constituents are removed from those that are not 
required from the plant material (Dhanani et al., 2017). In the 
present study, fifty grams of E. hirta L. whole plant powder 
upon soxhlet extraction resulted in a yield of 9.2g (percentage 
extract yield: 18.4% of dry weight) of aqueous (EHA) and 7.3g 
(percentage extract yield: 14.6% of dry weight) of methanol 
(EHM) crude extracts. The sample was further stored in a 
vacuum desiccator until further use.
Brine shrimp lethality bioassay
The brine shrimp lethality bioassay is widely used in the 
evaluation of toxicity of heavy metals, pesticides, plant extracts, 
etc. It’s a preliminary toxicity screen for further experiments on 
mammalian animal models (Price et al., 1974; Sorgeloos et al., 
1978). The brine shrimp assay has advantages of being rapid 
(24hrs), inexpensive, and simple. It easily utilizes a large number 
of organisms for statistical validation and requires no special 
equipment (McLaughlin et al., 1998). Both methanol and 
aqueous extracts of E. hirta L. exhibited significant mortality 
against Artemia nauplii. The percentage mortality for E. hirta 
L. whole plant aqueous and methanol extracts were depicted in 
(Table 1 and Table 2). Accordingly, EHA exhibited percentage 
mortality ranging from 27% to 73% whereas, EHM exhibited 
50% to 100% mortality at 1μg/ml to 1000μg/ml concentrations. 
EHM found to exhibit better mortality in A. nauplii when 
compared to EHA with an LC50 of 1±5.4μg/ml than the later 
43.25±9.6μg/ml. As mentioned by Meyer (1982), both the plant 
extracts exhibited an LC50 value of less than 1000μg/ml which 
is considered toxic. The methanol extract (EHM) in its highest 
concentration (1000μg/ml) had killed all the napulii treated.
Selective-cytotoxicity of EHA and EHM towards breast 
cancer cells
The efficacy of E. hirta L. extracts to inhibit the proliferation 
of cancer cells were further evaluated using two cancer cells 
(MDA-MB-231 and MCF-7) and a normal cell (VERO). Both 
the extracts have exhibited significant cytotoxicity in cancer 
cells when compared to normal cell (Figure 1 and Figure 2). 
Similar results were also made by Weisburg et al. (2004), wherein 
selective destruction of cancer cells was demonstrated. Among 
the study extracts, EHM had lower IC50 values of 82.81 and 
24.31μg/ml than EHA (92.86 and 53.08μg/ml) in MDA-MB-231 
and MCF-7 cells respectively. The extracts EHA and EHM were 
more effective in controlling the proliferation of MCF-7 cells 
rather than MDA-MB-231 cells. According to the American 
National Cancer Institute (NCI), the crude plant extract with an 
IC50 value <30μg/ml indicates the promising plant material for 
further cytotoxic agent purification (Suffness and Pezzuto, 1990). 
Accordingly, the extracts, EHA and EHM had lower IC50 values 
in MCF-7 cells, close and within the range of reported values by 
NCI when compared to the values of these extracts in MDA-
MB-231 cells. Moreover, VERO cells had recorded the maximum 
Table 1: Percentage mortality and LC50 value of A. sallina nauplii after 24hrs post exposure to the E. hirta L. whole plant aqueous 
extract (EHA).
Sl. No. Conc. of Plant extract 
(ppm or µg/mL)
Log C  
Conc.
Number of Surviving Nauplii after 24hrs Mean ± SD % Mortality Probit % 
Mortality
LC50
(µg/ml)T1 T2 T3 Total
1 1 0 8 7 7 22 7.33±5.77 27 4.39
43.25 ± 9.562 10 1 6 5 3 14 4.67±15.20 53 5.08
3 100 2 4 3 4 11 3.67±5.77 63 5.33
4 1000 3 4 2 2 8 2.67±11.50 73 5.61
Note: *T=Trial (No. of nauplii taken in each trial = 10); There is no probit value for 0% and 100%
Figure 1: Cytotoxicity of EHA on MDA-MB-231 and MCF-7 breast 
adenocarcinoma cells, and VERO cell lines
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IC50 values, 689.32 and 226.69μg/ml for the extracts EHA and 
EHM, respectively which indicates significantly (P<0.05) lower 
cytotoxicity in these cells. Hence, the results reveal that the 
E. hirta L. extracts were selectively targeting cancer cells and more 
specifically ER-positive breast cancer cells (MCF-7).
CONCLUSION
The study has revealed that the aqueous and methanol extracts 
of E. hirta L. plant had higher toxicity against the Brine shrimp, 
A. salina nauplii, where the methanol extract could annihilate 
all of the napulii in its highest concentration. Both the extracts 
exhibited higher cytotoxicity in cancer cells (MCF-7 and MDA-
MB-231) when compared to normal VERO cells. The results 
clearly indicate that both the extracts might possess beneficial 
therapeutic components specifically against ER-positive breast 
cancer with lesser damage towards normal cells. Hence, these 
extracts may further be exploited to isolate novel and potential 
sources of anticancer agents.
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Conc. of Plant extract 
(ppm or µg/mL)
Log C  
Conc.
Number of Surviving Nauplii after 24 hrs Mean ± SD % Mortality Probit % 
Mortality
LC50
(µg/ml)T1 T2 T3 Total
1 1 0 6 4 5 15 5.00±10.00 50 5.00 1 ± 5.39
2 10 1 4 3 3 10 3.33±5.77 67 5.44
3 100 2 2 2 3 7 2.33±5.77 77 5.74
4 1000 3 0 0 0 0 0.00±0.00 100 0
Note: *T=Trial (No. of nauplii taken in each trial = 10); There is no probit value for 0% and 100
Figure 2: Cytotoxicity of EHM on MDA-MB-231 and MCF-7 breast 
adenocarcinoma cells, and VERO cell lines
